This week we attended the @oxfordcancer.bsky.social and the @britsocimm.bsky.social -Oxford symposium 👩🏼‍💻🗒️👨‍💻 We are proud to share that at BSI-Oxford, our PostDoc @nabinapun.bsky.social won the prize for the best talk & our RA Paul won the best poster! 💪🏆🎉👏 Withers lab represent!

Already getting stuck in to an awesome 2026 with DPhil triage interviews starting on Monday for our CRUK centre core funded programme in Cancer Sciences with a pathway in cancer immunology.

Oxford Cancer@oxfordcancer.bsky.social · 8mo ago

As the year comes to a close, we’re reflecting on some of our 2025 highlights. 🥳 In June, we celebrated 2 years of the Oxford Cancer Immuno - Oncology Network (OCION). Read about some of OCION's key achievements on our website. 👇 www.cancer.ox.ac.uk/news/celebra... @timmunologist.bsky.social

Great to see that @oxcio.bsky.social Max is thinking big before his DPhil viva this morning! #croissantasaurusrex

Great discussion - patient groups are central to A/I partnerships -especially in the ED/prevention space….

Oxford Cancer@oxfordcancer.bsky.social · 8mo ago

Tim Elliott @timmunologist.bsky.social chairs today's panel discussion at #OXCODE25! The panel consider: 'Are industry/academia partnerships essential for advancing early detection and prevention research for patient benefit?' #OxfordCancer #Prevention #EarlyDetection

Congratulations Liz! Read her historical perspective article in @imtadvances.bsky.social

Congress starts today in Liverpool. Immunologists are battling the elements to be together! See you there.

Centre for Immuno-Oncology @oxcio.bsky.social · last yr.

A big part of the CIO team will be at #BSI2025 🤓 especially now that our very own Max from the @ggillesp.bsky.social lab is featured on the conference poster! Looking forward to an exciting few days in Liverpool 🔬✨ #Immunology #CIOonTour

🧬 Therapeutic cancer vaccines are back in focus! Advances in neo-antigen T cells, dendritic cell biology, and mRNA tech are paving the way for next-gen immunotherapy. Read the Open Access review: https://bit.ly/4cefxGm #CancerVaccines #Immunotherapy #mRNA #Oncology

🦠 DC3s in solid tumours can prime T cells and influence outcomes—boosting survival in some cancers, but promoting immunosuppression in others. 👉 https://bit.ly/3T2blRg #Immunotherapy #CancerImmunology

🔬 First head-to-head comparison of nuclear imaging for tumour CD8⁺ T cells shows [⁸⁹Zr]Zr-anti-CD8-IgG2a(silent) & [⁸⁹Zr]Zr-OT-I track T-cell infiltration & migration, aiding immunotherapy strategies. 👉 https://bit.ly/4ncWCzv #Immunotherapy #CD8Tcells #CancerResearch

Congratulations, Michael! 🎉

Oxford Medical Sciences Division@medsci.ox.ac.uk · 9mo ago

NEWS: Michael Bryan wins international award at Europe’s largest cancer conference Congratulations to Michael, DPhil in Cancer Science student, on the Best Poster Prize in CNS Tumours at the 2025 ESMO Congress. @oxfordcancer.bsky.social

Agreed. Pipette for Power!

Chris Thorpe@drchristhorpe.bsky.social · last yr.

Totally agree that standard biological data isn't built for AI. We need to think strategically about how we build better, less biased richer datasets specifically for machine learning

Offer cancer patients exercise on NHS major charity urges www.theguardian.com/society/2025...

Offer cancer patients exercise on NHS, major charity urges

Maggie’s says embedding activities such as yoga, tai chi and Nordic walking into care could boost chances of survival

theguardian.com

It seems someone removed the beautiful local multinational flag from the lamppost in East Oxford, but someone else has put up another one. nextdoor.co.uk/p/8TdLxGqcS_...

It seems someone removed the beautiful local multinational flag from the lamppost in East Oxford, but someone else has put up another one.

Join Nextdoor, an app for neighbourhoods where you can get local tips, buy and sell items, and more

nextdoor.co.uk

Incredible #infection #immunity #cancer #Bcells #Tcells Resource 👏 Top of the Human League 🙋‍♂️🙋‍♀️

bioRxiv Immunology@biorxiv-immuno.bsky.social · 10mo ago

HuBIE: The Human Blood Immunome Encyclopedia Of TCRs and BCRs in Bloodstream Infections and Cancer https://www.biorxiv.org/content/10.1101/2025.10.22.678684v1

From CAR-NK cells to checkpoint inhibitors, Blunt & Khakoo review how boosting NK-cell function could transform cancer therapy. 🔓 Open access: https://bit.ly/4j8dKEW #Immunotherapy #NKcells #CancerResearch

UK NK 2026 in Cardiff. January 9th. Be there. eventbrite.co.uk/e/uk-nk-confer… Hosted by Rich Stanton, Ceri Fielding & Eddie Wang

Need funding to attend your next conference? 💡 The BSI Conference Travel Grants can cover your travel costs - UK (£500), Europe (£700), rest of world (£1,000). The deadline is just over 1 week away (1 November), so submit your application soon! https://bit.ly/3U0jk2E

@witherslab.bsky.social going from strength to strength

Tumour-Immune Cell Dynamics Lab@witherslab.bsky.social · 10mo ago

In this weeks @oxcio.bsky.social seminar, our PostDoc Pascale presented her current progress on setting up #SingleCellSequencing experiments and their analysis for the @witherslab.bsky.social in Oxford! 🖥️💡🐭 Exciting!!!

Tick what? Many happy returns Felipe and well marked Anjum!

Centre for Immuno-Oncology @oxcio.bsky.social · 10mo ago

🤩CIO Cake Alert!! Anjum made this amazing lemon blueberry sponge cake for Felipe’s @galvez-cancino.bsky.social birthday from a TikTok recipe 🍰💙 But she promised to add it to our recipe collection making it truly generational-friendly!We’re so excited that homebaked cakes are back to CIO again 🎉

4 decades of IO – Celebrating 40 years of SITC. In 2009, we had a record meeting attendance and abstract submission! Attend this year's 40th Anniversary Annual Meeting and be a part of the science. https://www.sitcancer.org/2025/home

Wonderful day celebrating Paul Nurse after he steps down from being the Director @crick.ac.uk. We are all very grateful to him for having created an amazing institute.

@blackwellbooks.bsky.social please start posting

Great to see our work on preventive cancer vaccines, including LungVax, featured in this issue! @oxfordcancer.bsky.social @sarahblagden.bsky.social @timmunologist.bsky.social

The Economist@economist.com · last yr.

Progress in the fight against the disease has been slow, steady—and remarkable. Long may that continue

Join us for our DPhil in Cancer Science Open Day on Tuesday 2nd September at 12:30pm to find out how a DPhil can be the next step in your cancer research career development! Register via our Eventbrite link before 1st Sept⬇️ @oncology.ox.ac.uk @medsci.ox.ac.uk www.eventbrite.co.uk/e/university...

University of Oxford - DPhil in Cancer Science Open Day

Join the Virtual DPhil in Cancer Science Open Day to hear more about Oxford’s world-leading research training

eventbrite.co.uk

Looking forward to talking about #cancervaccines to *all* @CRUK research and innovation staff this afternoon at their fabulous away-day. Actually I’m a bit nervous😬

Amazing news for our Institute @kiroxford.bsky.social @ox.ac.uk 🎉🍾😀 ! Looking forward to working with our @manchester.ac.uk colleagues to understand better how envrionmental determinants drive chronic inflammatory diseases !

Kennedy Institute of Rheumatology@kiroxford.bsky.social · last yr.

Huge news! A £50M MRC CoRE will bring together Manchester & Oxford to study how environmental exposures cause chronic inflammatory disease. The CoRE will be Directed by Prof Judi Allen (Manchester) & co-Directed by Prof Dame Fiona Powrie, Director of the KIR. www.kennedy.ox.ac.uk/news/new-ps5...

Targeting monocyte dynamics in MS? In Immunotherapy Advances, Bibi et al. explore how shifting monocytes from inflammatory to reparative states may reshape MS treatment strategies. 📘 https://bit.ly/3EXOfaV #MS #Monocytes #Neuroinflammation

New research by Rui Zhao et al. shows that high anti-drug antibody (ADA) levels after 3 cycles of camrelizumab are linked to shorter survival in patients with advanced solid cancers. 📉 Higher ADA = lower drug levels = worse outcomes. 🔗 https://bit.ly/461mc5B #Immunotherapy #CancerResearch

🧬 Better understanding of immune rejection and evasion is setting the stage for next-gen therapies. Elizabeth Simpson reviews how foundational immunology is reshaping transplant and cancer treatment. 📖 https://bit.ly/44N141N #TransplantImmunology #Immunotherapy

🧩 Antigen presentation is complex - but imaging is bringing clarity. @doreenlau.bsky.social‬ & @timmunologist.bsky.social‬ review how advanced imaging illuminates T-cell–APC interactions, peptide-MHC dynamics, and more in cancer immunity. 📖 https://bit.ly/3TkIasN #CancerImmunology